Verfahren und Systeme zur Bestimmung des Therapiefensters, Nachweis, Vorhersage und Klassifizierung Neuroelektrischer, Herz- Und/oder Lungenereignisse und Optimierung der Behandlung dafür

Details

Veröffentlichungs-Nr.

EP4775140

Anmeldetag

16. November 2021

Veröffentlichung

15. Juli 2026

Rechtsraum

EP

Abstract

Methods and systems implement a variety of sensors, including in embodiments various combinations of EEG sensors, biochemical sensors, photoplethysmography (PPG) sensors, microphones, and accelerometers, to detect, predict, and/or classify various physiological events and/or conditions related to epilepsy, sleep apnea, and/or vestibular disorders. The events can include neuroelectrical events, cardiac events, and/or pulmonary events, among others. In some cases, the method and systems implement trained artificial intelligence (AI) models to detect, classify, and/or predict. The methods and systems are also capable of optimizing a treatment window, suggesting treatments that may improve the overall well-being of the patient (including improving pre- or post-event symptoms and effects), and/or interacting with various care providers.

Anmelder

Firmen

Epiminder Limited
Cochlear Limited

Land

🇦🇺 Australien